![](/img/cover-not-exists.png)
Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?
Ghazi, NicolaJournal:
Clinical Ophthalmology
DOI:
10.2147/opth.s3653
Date:
September, 2008
File:
PDF, 694 KB
2008